Skip to main content
Home Biologics
Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer

Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer

Value Proposition One in twelve men will be diagnosed with prostate cancer in their lifetime. Castration resistant prostate cancer, which resists traditional hormone therapies and continues to grow and often metastasize with poor survival outcomes,…

Read More

SUMO as a marker of cancer development and target for cancer therapy

SUMO as a marker of cancer development and target for cancer therapy

Value Proposition Cancer therapy remains challenging, and the production of new inhibitor therapies is stinted by the need for clear successful targets that will block tumor cell proliferation. Small ubiquitin-like modifier (SUMO) proteins and the…

Read More

Real-time wireless power transfer control for passive backscattering devices

Real-time wireless power transfer control for passive backscattering devices

A method and apparatus is disclosed herein for real-time wireless power transfer control. In one embodiment, a system comprises: an RF-energy harvesting sensor tag operable to generate a first backscatter signal and at least one…

Read More

GaN-based nitric oxide sensors and methods of making and using the same

GaN-based nitric oxide sensors and methods of making and using the same

Technology GaN-based heterojunction field effect transistor (HFET) sensors are provided with engineered, functional surfaces that act as pseudo-gates, modifying the drain current upon analyte capture. In some embodiments, devices for sensing nitric oxide (NO) species…

Read More

Cell line model of enzalutamide resistant prostate cancer

Cell line model of enzalutamide resistant prostate cancer

Traditionally, AR drug discovery has used both ligand and AR structure-based design, seeking antagonists by classical ligand binding assays or cellular reporter assays that assess functional antagonism of androgen-dependent transcriptional activation. While these largely empirical…

Read More

Cell line model of castration resistant prostate cancer

Cell line model of castration resistant prostate cancer

Traditionally, AR drug discovery has used both ligand and AR structure-based design, seeking antagonists by classical ligand binding assays or cellular reporter assays that assess functional antagonism of androgen-dependent transcriptional activation. While these largely empirical…

Read More

Methods of treatment in diseases treated with therapeutic proteins

Methods of treatment in diseases treated with therapeutic proteins

The present invention relates, in general, to a method of treating patients undergoing enzyme replacement therapy (ERT) or other therapy involving the administration of a proteinaceous therapeutic agent as well gene replacement therapy with non-viral…

Read More

HeLaDuke

HeLaDuke

Cell lines with enhanced sensitivity to estrogens and antiestrogens

Read More

Selective inhibition of mammalian gene expression by endogenous production of designed micro RNAs (miRNAs)

Selective inhibition of mammalian gene expression by endogenous production of designed micro RNAs (miRNAs)

This patent pending technology uses artificial miRNAs, transcribed from a plasmid or viral vector, to specifically and stably eliminate protein expression for individual gene targets both in vitro and in vivo. The unique temporal and/or…

Read More

Neural signal selection algorithm for a multichannel acquisition system

Neural signal selection algorithm for a multichannel acquisition system

Technology Methods, systems, and computer program for brain machine interfaces which transmitts neural signal information. It provides a method for selectively enabling and disabling channels in order to improve efficiency in the transmission and processing…

Read More

Aptamers to VMF

Aptamers to VMF

Focused aptamer libraries are constructed in accordance with a proteome (i.e., complex mixture of native biomolecules). The libraries may be screened to identify one or more candidate aptamers with desired biological activities other than specific…

Read More

Mice carrying functional single nucleotide polymorphisms in brain-specific trytophan hydroxylase(Tph2)

Mice carrying functional single nucleotide polymorphisms in brain-specific trytophan hydroxylase(Tph2)

We have developed mice expressing 2 different mutant alleles of the brain-specific tryptophan hydroxylase gene (Tph2). Tryptophan hydroxylase is the rate limiting enzyme involved in the synthesis of serotonin. These mice have significantly reduced levels…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us